Tyr1037

Site Information
TIVYLGDyLTVKKKG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 477654
Associated spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 ) , non-small cell squamous cell lung carcinoma ( 1 )
Relevant cell line - cell type - tissue:	NCI-H226 (pulmonary) ( 1 )

References
1	Farnsworth C (2004) CST Curation Set: 324; Year: 2004; Biosample/Treatment: cell line, NCI-H226/Serum starved &'\|\|' Serum starved; Disease: non-small cell squamous cell lung carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info

References

Farnsworth C (2004) CST Curation Set: 324; Year: 2004; Biosample/Treatment: cell line, NCI-H226/Serum starved &'||' Serum starved; Disease: non-small cell squamous cell lung carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info